EARNEST Partners’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-6
| Closed | -$49 | – | 816 |
|
|
2023
Q3 | $49 | Hold |
6
| – | – | ﹤0.01% | 1159 |
|
|
2023
Q2 | $48 | Hold |
6
| – | – | ﹤0.01% | 1168 |
|
|
2023
Q1 | $58 | Hold |
6
| – | – | ﹤0.01% | 1165 |
|
|
2022
Q4 | $188 | Hold |
6
| – | – | ﹤0.01% | 1156 |
|
|
2022
Q3 | $0 | Hold |
6
| – | – | ﹤0.01% | 1153 |
|
|
2022
Q2 | $0 | Hold |
6
| – | – | ﹤0.01% | 1176 |
|
|
2022
Q1 | $0 | Hold |
6
| – | – | ﹤0.01% | 1174 |
|
|
2021
Q4 | $1K | Hold |
6
| – | – | ﹤0.01% | 1115 |
|
|
2021
Q3 | $1K | Hold |
6
| – | – | ﹤0.01% | 1119 |
|
|
2021
Q2 | $1K | Hold |
6
| – | – | ﹤0.01% | 1122 |
|
|
2021
Q1 | $2K | Hold |
6
| – | – | ﹤0.01% | 1045 |
|
|
2020
Q4 | $1K | Hold |
6
| – | – | ﹤0.01% | 1122 |
|
|
2020
Q3 | $1K | Hold |
6
| – | – | ﹤0.01% | 1081 |
|
|
2020
Q2 | $2K | Hold |
6
| – | – | ﹤0.01% | 949 |
|
|
2020
Q1 | $1K | Hold |
6
| – | – | ﹤0.01% | 1017 |
|
|
2019
Q4 | $2K | Hold |
6
| – | – | ﹤0.01% | 1013 |
|
|
2019
Q3 | $2K | Hold |
6
| – | – | ﹤0.01% | 998 |
|
|
2019
Q2 | $3K | Hold |
6
| – | – | ﹤0.01% | 931 |
|
|
2019
Q1 | $3K | Hold |
6
| – | – | ﹤0.01% | 930 |
|
|
2018
Q4 | $3K | Hold |
6
| – | – | ﹤0.01% | 886 |
|
|
2018
Q3 | $5K | Hold |
6
| – | – | ﹤0.01% | 784 |
|
|
2018
Q2 | $4K | Buy |
+6
| New | +$4K | ﹤0.01% | 859 |
|